Clear Perspective Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Clear Perspective Advisors's BMY Position: Q4 2021 in Review
Clear Perspective Advisors reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q4 2021, selling an estimated $108K and leaving 9,680 shares worth $604K. The position accounts for 0.18% of the portfolio, ranked #85.
Clear Perspective Advisors first reported a position in BMY in Q4 2016 and has held it in 21 quarters since. The position peaked at $778K in Q2 2021. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- Clear Perspective Advisors held 9,680 shares of Bristol-Myers Squibb worth $604K as of Q4 2021.
- Clear Perspective Advisors sold 1,846 Bristol-Myers Squibb shares in Q4 2021, an estimated $108K.
- Bristol-Myers Squibb made up 0.18% of Clear Perspective Advisors's portfolio in Q4 2021, its #85 holding.
- Clear Perspective Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 21 quarters since.
- Clear Perspective Advisors's Bristol-Myers Squibb position peaked at $778K in Q2 2021.
- 2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on Clear Perspective Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.